Accelerate your biomarker driven drug development
Our expertise in advanced cancer genomic analysis ranges from sample preparation through data interpretation and analysis. We specialize in high-throughput CGP, proprietary algorithms to identify complex genomic alterations and signatures and have developed novel plasma-based technologies for non-invasive approaches in cancer. Our flexible line of kitted tissue and liquid biopsy-based solutions empowers researchers to unlock the full power of genomic data for oncology.
Don’t see an existing solution that meets your needs?